Oral Remdesivir: NV-387 Nanoviricide Micelle Formulation
NanoViricides Inc. filed recent SEC 8-K documents detailing ongoing pharmaceutical development, including the encapsulation of remdesivir within NV-387 nanoviricide micelles as an oral formulation. This regulatory update highlights the company’s … Read More